JNJ Holds Steady Near 52-Week High Amid Valuation Concerns

Johnson & Johnson (NYSE:JNJ) is holding steady near its 52-week high of $274.90, with shares trading at $261.81.

The company's strong pipeline and resilient guidance have driven a 54.82% increase in stock price over the past year, outperforming the S&P 500 by 31.5 percentage points.

CEO Joaquin Duato has pointed to 'line of sight to double-digit growth by the end of the decade', with growth engines such as DARZALEX and TREMFYA contributing significantly to revenue.

However, some concerns exist regarding valuation, with a trailing P/E of 30 well above historical ranges, and quarterly earnings growth at -0.9% year over year.